Francesco Caciagli

Title: Francesco Caciagli: Innovator in G-Protein Coupled Receptor Research

Introduction

Francesco Caciagli is a notable inventor based in Chieti, Italy. He has made significant contributions to the field of biochemistry, particularly in the area of G-protein coupled receptors. With a total of 2 patents to his name, Caciagli's work is paving the way for advancements in cellular biology and pharmacology.

Latest Patents

Caciagli's latest patents focus on transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors. The first patent discloses cell lines transformed to express G-Protein Coupled Receptor GPCR22, which are useful for identifying guanosine analogues and other ligands to the receptor. Techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cells to express GPCR22 are also detailed. The transformed cell lines may be instrumental in identifying guanosine analogs and their functional equivalents. The second patent reiterates these findings, emphasizing the methods of use for identifying binding compounds through GPCR22-transformed cell lines.

Career Highlights

Caciagli is currently associated with Libramen Naturals Inc., where he continues to innovate and contribute to research in his field. His work is characterized by a commitment to advancing scientific understanding and practical applications of G-protein coupled receptors.

Collaborations

Caciagli collaborates with esteemed colleagues, including Michel P Rathbone and Shucui Jiang. Their combined expertise enhances the research efforts and outcomes in their projects.

Conclusion

Francesco Caciagli's contributions to the field of biochemistry, particularly through his patents on GPCR22, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future applications in medicine and pharmacology.